Biofidelity Launches Test Offering Rapid Genomic Profiling for NSCLC Patients
Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.
Read MorePosted by Andy Lundin | Nov 21, 2024 | Lung Cancer, Molecular Diagnostics |
Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.
Read MorePosted by Andy Lundin | Nov 20, 2024 | Digital Pathology, Lung Cancer |
Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lung Cancer |
Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MorePosted by Andy Lundin | Nov 15, 2024 | Lung Cancer, Urine Analyzers |
Researchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Microscopy |
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read More